Predictive Safety Analyst - Genetic Toxicology

At Roche, we are committed to ensuring the safety and efficacy of our products for patients worldwide. As a Predictive Safety Analyst - Genetic Toxicology, you will play a vital role in assessing the potential risks of our pharmaceuticals and contributing to the development of safe and effective treatments. We are seeking a highly motivated individual with a strong background in genetic toxicology and a passion for improving human health. If you are a detail-oriented, analytical thinker with excellent communication skills, we invite you to join our dynamic team and make a meaningful impact on the future of healthcare.

1. Conduct genetic toxicology studies and analyze data to assess the safety and efficacy of Roche pharmaceutical products.
2. Identify potential risks and side effects of pharmaceuticals and communicate findings to relevant teams.
3. Collaborate with cross-functional teams to develop and implement safety assessment strategies.
4. Stay up-to-date with current research and developments in genetic toxicology to inform decision making.
5. Ensure compliance with regulatory guidelines and industry standards for safety assessments.
6. Develop and maintain databases and other tools for tracking and analyzing safety data.
7. Prepare reports and presentations summarizing safety assessment findings for internal and external stakeholders.
8. Communicate complex scientific information in a clear and concise manner to non-technical audiences.
9. Participate in and contribute to team discussions and meetings to drive continuous improvement in safety assessment processes.
10. Act as a subject matter expert on genetic toxicology and provide guidance and support to colleagues as needed.

According to JobzMall, the average salary range for a Predictive Safety Analyst - Genetic Toxicology in Basel, Switzerland is CHF 130,000 - CHF 180,000 per year. This range may vary depending on factors such as experience, education, and specific job responsibilities.

Roche Holding AG operates as a research healthcare company. It operates through the diagnostics and pharmaceuticals segments. The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.